Nuveen LLC acquired a new stake in shares of Nature's Sunshine Products, Inc. (NASDAQ:NATR - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 34,831 shares of the company's stock, valued at approximately $437,000. Nuveen LLC owned approximately 0.19% of Nature's Sunshine Products at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. GAMMA Investing LLC raised its holdings in shares of Nature's Sunshine Products by 2,090.2% during the 1st quarter. GAMMA Investing LLC now owns 2,234 shares of the company's stock valued at $28,000 after buying an additional 2,132 shares in the last quarter. Deutsche Bank AG purchased a new position in shares of Nature's Sunshine Products during the 4th quarter valued at about $103,000. Wells Fargo & Company MN raised its holdings in shares of Nature's Sunshine Products by 28.8% during the 4th quarter. Wells Fargo & Company MN now owns 7,209 shares of the company's stock valued at $106,000 after buying an additional 1,611 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Nature's Sunshine Products by 346.9% during the 4th quarter. BNP Paribas Financial Markets now owns 11,719 shares of the company's stock valued at $172,000 after buying an additional 9,097 shares in the last quarter. Finally, Bridgeway Capital Management LLC raised its holdings in shares of Nature's Sunshine Products by 24.1% during the 4th quarter. Bridgeway Capital Management LLC now owns 17,514 shares of the company's stock valued at $257,000 after buying an additional 3,400 shares in the last quarter. 79.40% of the stock is owned by hedge funds and other institutional investors.
Nature's Sunshine Products Price Performance
Nature's Sunshine Products stock traded down $0.20 during trading hours on Friday, reaching $17.14. The company had a trading volume of 82,208 shares, compared to its average volume of 115,389. The company has a 50-day moving average price of $15.78 and a 200 day moving average price of $14.28. The firm has a market cap of $302.35 million, a price-to-earnings ratio of 23.16 and a beta of 1.11. Nature's Sunshine Products, Inc. has a 12-month low of $11.01 and a 12-month high of $18.06.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $0.35 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.19. The business had revenue of $114.75 million for the quarter, compared to analysts' expectations of $113.10 million. Nature's Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%. Nature's Sunshine Products has set its FY 2025 guidance at EPS.
Insiders Place Their Bets
In other news, CAO Jonathan David Lanoy sold 5,000 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $16.51, for a total transaction of $82,550.00. Following the transaction, the chief accounting officer directly owned 50,051 shares of the company's stock, valued at approximately $826,342.01. The trade was a 9.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Nathan G. Brower sold 9,996 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $16.54, for a total value of $165,333.84. Following the transaction, the executive vice president directly owned 48,277 shares in the company, valued at $798,501.58. This trade represents a 17.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,879,275 shares of company stock valued at $33,123,599 over the last three months. 4.70% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
A number of equities analysts have commented on NATR shares. Canaccord Genuity Group lifted their price target on Nature's Sunshine Products from $21.00 to $22.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. DA Davidson reaffirmed a "buy" rating and issued a $19.00 price target on shares of Nature's Sunshine Products in a research note on Tuesday, June 3rd. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Nature's Sunshine Products presently has an average rating of "Buy" and a consensus target price of $19.67.
Check Out Our Latest Analysis on Nature's Sunshine Products
Nature's Sunshine Products Profile
(
Free Report)
Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Featured Articles

Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.